Increased prevalence of autoimmune disorders and autoantibodies in parents of children with Opsoclonus-Myoclonus Syndrome (OMS)

Neuropediatrics

Volumn 38, Issue 3, 2007, Pages 114-116

  Krasenbrink, I ^a   Fuhlhuber V ^a   Juhasz Boess, I ^a   Stolz, E ^a   Hahn, A ^b   Kaps, M ^a   Hero, B ^c   Blaes, F ^a,b  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antineuronal; Autoantibodies; Autoimmunity; Opsoclonus myoclonus syndrome; Parents

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MYOCLONUS; OPSOCLONUS; OPSOCLONUS MYOCLONUS SYNDROME; PRIORITY JOURNAL; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; NEUROBLASTOMA; OPSOCLONUS-MYOCLONUS SYNDROME; PARENTS; PREVALENCE;

EID: 36649025906     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985906     Document Type: Article

References (10)

1. Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NK, Dalmau J. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol 2003; 53: 347-353
2. Blaes F, Holzer G, Merkelbach S, Strittmatter M, Schimrigk K, Schäfer KH. Detection of autoantibodies by indirect immunofluorescence in the diagnostics of neurological diseases. J Lab Med 1998; 22: 33-39
3. Blaes F, Fühlhuber V, Korfei M, Tschernatsch M, Behnisch W, Rostasy K et al. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann Neurol 2005; 58: 313-317
4. Cataldo F, Marino V. Increased prevalence of autoimmune diseases in first-degree relatives of patients with celiac disease. J Pediatr Gastroenterol Nutr 2003; 36: 470-473
5. Corporaal S, Bijl M, Kallenberg CG. Familial occurrence of autoimmune diseases and autoantibodies in a Caucasian population of patients with systemic lupus erythematosus. Clin Rheumatol. 2002; 21: 108-113
6. Hanukoglu A, Mizrachi A, Dalai I, Admoni O, Rakover Y, Bistritzeer Z et al. Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree parents: a multicenter study. Diabetes Care. 2003; 26: 1235-1240
7. Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens: 2003; 62: 162-169
8. Korfei M, Fühlhuber V, Schmidt-Wöll T, Kaps M, Preissner KT, Blaes F. Functional characterisation of autoantibodies from patients with pediatric opsoclonus, myoclonus syndrome. J Neuroimmunol. 2005; 170: 150-157
9. Franzatelli MR. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol: 1996; 19: 1-47
10. Petaros P, Martelossi S, Tommasini A, Torre G, Caradonna M, Ventura A. Prevalence of Autoimmune disorders in parents of patients with celiac disease. Dig Dis Sci 2002; 47: 1427-1431